Deoxyribonuclease I Inhibitory Properties, Molecular Docking and Molecular Dynamics Simulations of 1-(Pyrrolidin-2-yl)propan-2-one Derivatives.


Journal

Chemistry & biodiversity
ISSN: 1612-1880
Titre abrégé: Chem Biodivers
Pays: Switzerland
ID NLM: 101197449

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 05 12 2020
accepted: 02 02 2021
pubmed: 3 2 2021
medline: 9 7 2021
entrez: 2 2 2021
Statut: ppublish

Résumé

Deoxyribonuclease I (DNase I) inhibitory properties of two 1-(pyrrolidin-2-yl)propan-2-one derivatives were examined in vitro. Determined IC

Identifiants

pubmed: 33529484
doi: 10.1002/cbdv.202000996
doi:

Substances chimiques

Enzyme Inhibitors 0
Pyrrolidines 0
DNASE1 protein, human EC 3.1.21.1
Deoxyribonuclease I EC 3.1.21.1
pyrrolidine LJU5627FYV
Propane T75W9911L6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2000996

Subventions

Organisme : Ministry of Education, Science and Technological Development of the Republic of Serbia
ID : 451-03-68/2020-14/200113
Organisme : Ministry of Education, Science and Technological Development of the Republic of Serbia
ID : 451-03-68/2020-14/200026
Organisme : Faculty of Medicine of the University of Niš
ID : 40
Organisme : D. E. Shaw Research

Informations de copyright

© 2021 Wiley-VHCA AG, Zurich, Switzerland.

Références

A. G. Baranovskii, V. N. Buneva, G. A. Nevinsky, ‘Human deoxyribonucleases’, Biochemistry 2004, 69, 587-601.
M. McCarty, ‘Purification and properties of desoxyribonuclease isolated from beef pancreas’, J. Gen. Physiol. 1946, 29, 123-139.
L. Lauková, B. Konečná, Ľ. Janovičová, B. Vlková, P. Celec, ‘Deoxyribonucleases and their applications in biomedicine’, Biomol. Eng. 2020, 10, 1036.
D. Shiokawa, S. I. Tanuma, ‘Characterization of human DNase I family endonucleases and activation of DNase γ during apoptosis’ Biochemistry 2001, 40, 143-152.
D. Eulitz, H. G. Mannherz, ‘Inhibition of deoxyribonuclease I by actin is to protect cells from premature cell death’, Apoptosis 2007, 12, 1511-1521.
K. Samejima, W. C. Earnshaw, ‘Trashing the genome: the role of nucleases during apoptosis’, Nat. Rev. Mol. Cell Biol. 2005, 6, 677-688.
M. Oliveri, A. Daga, C. Cantoni, C. Lunardi, R. Millo, A. Ruccetti, ‘DNase I mediates internucleosomal DNA degradation in human cells undergoing drug-induced apoptosis’, Eur. J. Immunol. 2001, 31, 743-751.
D. Thiyagarajan, O. P. Rekvig, N. Seredkina, ‘TNFα amplifies DNaseI expression in renal tubular cells while IL-1β promotes nuclear DNaseI translocation in an endonuclease-inactive form’, PLoS One 2015, 10, e0129485.
A. Smelcerovic, A. Zivkovic, B. S. Ilic, A. Kolarevic, B. Hofmann, D. Steinhilber, H. Stark, ‘4-(4-Chlorophenyl)thiazol-2-amines as pioneers of potential neurodegenerative therapeutics with anti-inflammatory properties based on dual DNase I and 5-LO inhibition’, Bioorg. Chem. 2020, 95, 103528.
A. Kolarevic, D. Yancheva, G. Kocic, A. Smelcerovic, ‘Deoxyribonuclease inhibitors’, Eur. J. Med. Chem. 2014, 88, 101-111.
A. Kolarević, B. S. Ilić, N. Anastassova, A. Ts. Mavrova, D. Yancheva, G. Kocić, A. Šmelcerović, ‘Benzimidazoles as novel deoxyribonuclease I inhibitors’, J. Cell. Biochem. 2018, 119, 8937-8947.
A. Ts. Mavrova, S. Dimov, D. Yancheva, A. Kolarević, B. S. Ilić, G. Kocić, A. Šmelcerović, ‘Synthesis and DNase I inhibitory properties of some 5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidines’, Bioorg. Chem. 2018, 80, 693-705.
A. Kolarević, B. S. Ilić, G. Kocić, Z. Džambaski, A. Šmelcerović, B. P. Bondžić, ‘Synthesis and DNase I inhibitory properties of some 4-thiazolidinone derivatives’, J. Cell. Biochem. 2019, 120, 264-274.
A. Kolarevic, A. Pavlovic, A. Djordjevic, J. Lazarevic, S. Savic, G. Kocic, M. Anderluh, A. Smelcerovic, ‘Rutin as deoxyribonuclease I inhibitor’, Chem. Biodiversity 2019, 16, e1900069.
B. P. Bondžić, Z. Džambaski, A. Kolarević, A. Đorđević, M. Anderluh, A. Šmelcerović, ‘Synthesis and DNase I inhibitory properties of new benzocyclobutane-2,5-diones’, Future Med. Chem. 2019, 11, 2415-2426.
http://www.swissadme.ch; Accessed November 16, 2020.
A. Diana, O. Michielin, V. Zoete, ‘SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules’, Sci. Rep. 2017, 7, 42717.
http://admet.scbdd.com; Accessed January 27, 2021.
J. Dong, N. N. Wang, Z. J. Yao, L. Zhang, Y. Cheng, D. Ouyang, A. P. Lu, D. S. Cao, ‘ADMETlab: a platform for systematic ADMET evaluation based on a comprehensively collected ADMET database’, J. Cheminf. 2018, 10, 29.
T. Sander, J. Freyss, M. von Korff, C. Rufener, ‘DataWarrior: an open-source program for chemistry aware data visualization and analysis’, J. Chem. Inf. Model. 2015, 55, 460-473.
C. A. Lipinski, F. Lombardo, B. W. Dominy, P. J. Feeney, ‘Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings’, Adv. Drug Delivery Rev. 1997, 23, 3-25.
https://nerdd.zbh.uni-hamburg.de/hitdexter; Accessed January 27, 2021.
C. Stork, Y. Chen, M. Šícho, J. Kirchmair, ‘Hit Dexter 2.0: Machine-learning models for the prediction of frequent hitters’, J. Chem. Inf. Model. 2019, 59, 1030-1043.
S. Soga, H. Shirai, M. Kobori, N. Hirayama, ‘Use of amino acid composition to predict ligand-binding sites’, J. Chem. Inf. Model. 2007, 47, 400-406.
MOE, Molecular Operating Environment 2019.0101, Chemical Computing Group ULC, Montreal, QC, Canada, 2019.
S. A. Weston, A. Lahm, D. Suck, ‘X-ray structure of the DNase I-d(GGTATACC)2 complex at 2.3 Å resolution’, J. Mol. Biol. 1992, 226, 1237-1256.
S. J. Jones, A. F. Worrall, B. A. Connolly, ‘Site-directed mutagenesis of the catalytic residues of bovine pancreatic deoxyribonuclease I’, J. Mol. Biol. 1996, 264, 1154-1163.
C. Q. Pan, J. S. Uumer, A. Herzka, R. A. Lazarus, ‘Mutational analysis of human DNase I at the DNA binding interface: implications for DNA recognition, catalysis, and metal ion dependence’, Protein Sci. 1998, 7, 628-636.
M. Gueroult, D. Picot, J. Abi-Ghanem, B. Hartmann, M. Baaden, ‘How cations can assist DNase I in DNA binding and hydrolysis’, PLoS Comput. Biol. 2010, 6, e1001000.
Desmond, Desmond Molecular Dynamics System, version 2018.4, D. E. Shaw Research, New York, NY, 2018.
K. Lui, H. Kokubo, ‘Exploring the stability of ligand binding modes to proteins by molecular dynamics simulations: a cross-docking study’, J. Chem. Inf. Model. 2017, 57, 2514-2522.

Auteurs

Budimir S Ilić (BS)

University of Niš, Faculty of Medicine, Department of Chemistry, Blvd. Dr. Zorana Đinđića 81, 18000, Niš, Serbia.

Mihajlo Gajić (M)

University of Niš, Faculty of Medicine, Department of Pharmacy, Blvd. Dr. Zorana Đinđića 81, 18000, Niš, Serbia.

Bojan P Bondžić (BP)

University of Belgrade, Institute of Chemistry, Technology and Metallurgy, Njegoševa 12, 11000, Belgrade, Serbia.

Zdravko Džambaski (Z)

University of Belgrade, Institute of Chemistry, Technology and Metallurgy, Njegoševa 12, 11000, Belgrade, Serbia.

Gordana Kocić (G)

University of Niš, Faculty of Medicine, Department of Biochemistry, Blvd. Dr. Zorana Đinđića 81, 18000, Niš, Serbia.

Andrija Šmelcerović (A)

University of Niš, Faculty of Medicine, Department of Chemistry, Blvd. Dr. Zorana Đinđića 81, 18000, Niš, Serbia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH